Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


25.04.2022

7 Am J Cardiol
1 Circ Arrhythm Electrophysiol
2 Circ Cardiovasc Imaging
2 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
12 Circ Heart Fail
1 Circ Res
5 Circulation
1 Clin Cardiol
5 Eur Heart J
6 Eur J Heart Fail
1 Hypertension
7 Int J Cardiol
8 J Am Coll Cardiol
8 J Card Fail
4 J Cardiol
1 PLoS Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. SUN D, Schaff HV, McKenzie TJ, Nishimura RA, et al
    Safety of Bariatric Surgery in Obese Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2022;167:93-97.
    PubMed         Abstract available

  2. DONG A, Bhatia SK
    Adverse Events Attributed to Heartware and HeartMate Ventricular Assist Devices in the Prepandemic and Pandemic Eras.
    Am J Cardiol. 2022;166:142-144.
    PubMed        

  3. SUNAGA T, Ryo Y
    Potential Safety Signals for Rhabdomyolysis Associated With High-Potency Statin Use With or Without Sacubitril/Valsartan.
    Am J Cardiol. 2022;166:127-130.
    PubMed         Abstract available

  4. MELIOTA G, Lombardi M, Benevento M, Console V, et al
    Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease.
    Am J Cardiol. 2021 Dec 21. pii: S0002-9149(21)01155.
    PubMed         Abstract available

  5. MADSEN JM, Glinge C, Jabbari R, Nepper-Christensen L, et al
    Comparison of Effect of Ischemic Postconditioning on Cardiovascular Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention With Versus Without Thrombectomy.
    Am J Cardiol. 2021 Dec 17. pii: S0002-9149(21)01137.
    PubMed         Abstract available

  6. FUSCO F, Scognamiglio G, Guarguagli S, Merola A, et al
    Prognostic Relevance of Thyroid Disorders in Adults With Congenital Heart Disease.
    Am J Cardiol. 2022;166:107-113.
    PubMed         Abstract available

  7. JIANG Y, Boris AF, Zhu Y, Gan H, et al
    Incidence, Clinical Characteristics and Short-Term Prognosis in Patients With Cardiogenic Shock and Various Left Ventricular Ejection Fractions After Acute Myocardial Infarction.
    Am J Cardiol. 2022 Jan 2. pii: S0002-9149(21)01185.
    PubMed         Abstract available


    Circ Arrhythm Electrophysiol

  8. ALTHOUSE AD, Jain SK, Shalaby A, Singh M, et al
    Feasibility of a Randomized Clinical Trial of Cardiac Resynchronization Therapy With or Without an Implantable Defibrillator in Older Patients.
    Circ Arrhythm Electrophysiol. 2022;15:e010795.
    PubMed        


    Circ Cardiovasc Imaging

  9. LEE HJ, Kim HK, Rhee TM, Choi YJ, et al
    Left Atrial Reservoir Strain-Based Left Ventricular Diastolic Function Grading and Incident Heart Failure in Hypertrophic Cardiomyopathy.
    Circ Cardiovasc Imaging. 2022;15:e013556.
    PubMed         Abstract available

  10. ELAD B, Lessick J, Adler Z, Caspi O, et al
    Three-Dimensional Computed Tomography Reconstruction for Diagnosis of Left Ventricular Assist Device Outflow Graft Twist.
    Circ Cardiovasc Imaging. 2022 Mar 29:CIRCIMAGING121013714.
    PubMed        


    Circ Cardiovasc Interv

  11. VELAGALETI RS, Vetter J, Parker R, Kurgansky KE, et al
    Change in Left Ventricular Ejection Fraction With Coronary Artery Revascularization and Subsequent Risk for Adverse Cardiovascular Outcomes.
    Circ Cardiovasc Interv. 2022 Apr 12:101161CIRCINTERVENTIONS121011284.
    PubMed         Abstract available

  12. SUGIURA A, Kavsur R, Spieker M, Iliadis C, et al
    Recurrent Mitral Regurgitation After MitraClip: Predictive Factors, Morphology, and Clinical Implication.
    Circ Cardiovasc Interv. 2022 Feb 23:CIRCINTERVENTIONS121010895.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  13. GULATI G, Upshaw J, Wessler BS, Brazil RJ, et al
    Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models.
    Circ Cardiovasc Qual Outcomes. 2022 Mar 31:101161CIRCOUTCOMES121008487.
    PubMed         Abstract available


    Circ Heart Fail

  14. BROWN SH, Xu M, Chang RS, Cohen SS, et al
    Physical Activity, Sedentary Time, and Heart Failure Risk in Low-Income Black and White Adults Living in the Southeastern United States.
    Circ Heart Fail. 2022 Apr 21:101161CIRCHEARTFAILURE121009436.
    PubMed        

  15. AONUMA T, Moukette B, Kawaguchi S, Barupala NP, et al
    MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic Hoxa4.
    Circ Heart Fail. 2022;15:e008686.
    PubMed         Abstract available

  16. ARAJ FG, Hackmann AE
    Letter by Araj and Hackmann Regarding Article, "Liberation From Venoarterial Extracorporeal Membrane Oxygenation: A Review".
    Circ Heart Fail. 2022;15:e009079.
    PubMed        

  17. BATRA J, DeFilippis EM, Golob S, Clerkin K, et al
    Impact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies.
    Circ Heart Fail. 2022 Jan 31:CIRCHEARTFAILURE121008968.
    PubMed         Abstract available

  18. VALLABHAJOSYULA S, Katz JN, Menon V
    Quantification of Vasoactive Medications and the "Pharmaco-Mechanical Continuum" in Cardiogenic Shock.
    Circ Heart Fail. 2022;15:e008736.
    PubMed        

  19. KIMMELSTIEL C, Everett KD, Jain P, Miyashita S, et al
    Transcatheter Mitral Intervention Relieves Dynamic Outflow Obstruction and Reduces Cardiac Workload in Hypertrophic Cardiomyopathy.
    Circ Heart Fail. 2022;15:e009171.
    PubMed        

  20. THENAPPAN T
    Early Use of Phosphodiesterase Inhibitors After Left Ventricular Assist Device: Is It Time to Rethink?
    Circ Heart Fail. 2022;15:e009437.
    PubMed        

  21. GRANDIN EW, Gulati G, Nunez JI, Kennedy K, et al
    Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis.
    Circ Heart Fail. 2022;15:e008613.
    PubMed         Abstract available

  22. SUN W, Zou H, Yong Y, Liu B, et al
    The RAISE Trial: A Novel Device and First-in-Man Trial.
    Circ Heart Fail. 2022;15:e008362.
    PubMed         Abstract available


  23. Correction to: "Polygenic Score for beta-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure".
    Circ Heart Fail. 2022;15:e000075.
    PubMed        

  24. SUNG K, McCain J, King KR, Hong K, et al
    Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine.
    Circ Heart Fail. 2022;15:e009321.
    PubMed        

  25. NAITO Y, Sawada H, Yasumura S, Horimatsu T, et al
    Iron Deficiency Induces Heart Failure With Ectopic Cardiac Calcification in Mice With Metabolic Syndrome.
    Circ Heart Fail. 2022 Apr 21:101161CIRCHEARTFAILURE121009034.
    PubMed        


    Circ Res

  26. STACHOWSKI-DOLL MJ, Papadaki M, Martin TG, Ma W, et al
    GSK-3beta Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.
    Circ Res. 2022;130:871-886.
    PubMed         Abstract available


    Circulation

  27. ADAMSON C, Docherty KF, Heerspink HJL, de Boer RA, et al
    Initial Decline ("dip") in Estimated Glomerular Filtration Rate Following Initiation of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction: Insights from DAPA-HF.
    Circulation. 2022 Apr 20. doi: 10.1161/CIRCULATIONAHA.121.058910.
    PubMed         Abstract available

  28. GRONDA E, Colivicchi F, Zuccala G
    Letter by Gronda et al Regarding Article, "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial".
    Circulation. 2022;145:e839-e840.
    PubMed        

  29. MAKAREWICH CA, Thum T
    Exercise-Induced Long Noncoding RNAs As New Players in Cardiac Hypertrophy.
    Circulation. 2022;145:1234-1237.
    PubMed        

  30. LI H, Trager LE, Liu X, Hastings MH, et al
    lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth.
    Circulation. 2022;145:1218-1233.
    PubMed         Abstract available

  31. FENG G, Bajpai G, Ma P, Koenig A, et al
    CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
    Circulation. 2022;145:765-782.
    PubMed         Abstract available


    Clin Cardiol

  32. HWANG JW, Kim DG, Kim H, Kwak JJ, et al
    Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades).
    Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23792.
    PubMed         Abstract available


    Eur Heart J

  33. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed         Abstract available

  34. OLIVELLA A, Mendez AB, Ferreira-Gonzalez I
    Mixing the fat with water: are normal natriuretic peptide heart failure with preserved ejection fraction patients just more obese?
    Eur Heart J. 2022 Apr 20. pii: 6571173. doi: 10.1093.
    PubMed        

  35. VAN DER MEER P, Rienstra M, van Veldhuisen DJ
    A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
    Eur Heart J. 2022 Apr 20. pii: 6571185. doi: 10.1093.
    PubMed        

  36. VERBRUGGE FH, Borlaug BA
    Heart failure with normal natriuretic peptide levels: more fat, and that is the main problem.
    Eur Heart J. 2022 Apr 20. pii: 6571179. doi: 10.1093.
    PubMed        

  37. AKTAA S, Batra G, Cleland JGF, Coats A, et al
    Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2022 Apr 20. pii: 6571493. doi: 10.1093.
    PubMed         Abstract available


    Eur J Heart Fail

  38. SINHA A, Yancy CW, Patel RB
    Tipping the scale toward a more accurate and equitable assessment of heart failure with reduced ejection fraction pharmacotherapy eligibility: a call to incorporate cystatin C in estimating glomerular filtration rate.
    Eur J Heart Fail. 2022 Apr 12. doi: 10.1002/ejhf.2505.
    PubMed        

  39. VOORDES GHD, Heerspink HJL, Ter Maaten JM
    The interplay between sacubitril/valsartan, heart failure with preserved ejection fraction, diabetes and kidney function.
    Eur J Heart Fail. 2022 Apr 12. doi: 10.1002/ejhf.2501.
    PubMed        

  40. KALOGEROPOULOS AP, Butler J
    Uptitrating versus adding heart failure with reduced ejection fraction medications: bring more players to the game.
    Eur J Heart Fail. 2022 Apr 13. doi: 10.1002/ejhf.2507.
    PubMed        

  41. MCNAUGHTON CD, McConnachie A, Cleland JG, Spertus JA, et al
    Quality of life assessed six months after hospitalisation for acute heart failure: An analysis from REPORT-HF (International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).
    Eur J Heart Fail. 2022 Apr 16. doi: 10.1002/ejhf.2508.
    PubMed         Abstract available

  42. STRAW S, Gierula J, Witte KK
    Designing clinical trials in heart failure with preserved ejection fraction: quality over quantity?
    Eur J Heart Fail. 2022 Apr 21. doi: 10.1002/ejhf.2510.
    PubMed        

  43. EMDIN M, Aimo A, Castiglione V
    Is Targeting Cyclic Guanosine Monophosphate by Vericiguat Effective to Treat Ischaemic Heart Failure with Reduced Ejection Fraction? Yes, It Is.
    Eur J Heart Fail. 2022 Apr 21. doi: 10.1002/ejhf.2511.
    PubMed        


    Hypertension

  44. VASAN RS, Pan S, Xanthakis V, Beiser A, et al
    Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study.
    Hypertension. 2022;79:1045-1056.
    PubMed         Abstract available


    Int J Cardiol

  45. SABATINO J, Di Salvo G
    The new pandemic: ACHD HF.
    Int J Cardiol. 2022;356:51-52.
    PubMed        

  46. IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
    Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease.
    Int J Cardiol. 2022;356:98-104.
    PubMed         Abstract available

  47. ROSENTHAL LL, Ulrich SM, Zimmerling L, Brenner P, et al
    Pediatric heart transplantation in infants and small children under 3years of age: Single center experience - "Early and long-term results".
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00482.
    PubMed         Abstract available

  48. ELBADAWI A, Tan BE, Assaf Y, Megaly M, et al
    Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
    Int J Cardiol. 2022 Apr 15. pii: S0167-5273(22)00553.
    PubMed         Abstract available

  49. RIZZO M, Cianflone D, Maranta F
    Treatment of diabetes and heart failure: Facts and hopes.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00549.
    PubMed        

  50. CASTIGLIONE V, Vergaro G, Emdin M
    Targeting precipitants to prevent heart failure hospitalization. Does season matter?
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00561.
    PubMed        

  51. BERGONTI M, Spera F, Tijskens M, Bonomi A, et al
    A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure.
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00554.
    PubMed         Abstract available


    J Am Coll Cardiol

  52. MENTIAS A, Aminian A, Youssef D, Pandey A, et al
    Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
    J Am Coll Cardiol. 2022;79:1429-1437.
    PubMed         Abstract available

  53. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    PubMed         Abstract available

  54. KHAN SS, Beach LB, Yancy CW
    Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7.
    J Am Coll Cardiol. 2022;79:1530-1541.
    PubMed         Abstract available

  55. INCIARDI RM, Claggett B, Minamisawa M, Shin SH, et al
    Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
    J Am Coll Cardiol. 2022;79:1549-1561.
    PubMed         Abstract available

  56. NEGISHI K, Pathan F
    Novel Left Atrial Markers for Risk Stratification of Heart Failure: Ready for Prime Time?
    J Am Coll Cardiol. 2022;79:1562-1564.
    PubMed        

  57. LAU ES, Wang D, Roberts M, Taylor CN, et al
    Infertility and Risk of Heart Failure in the Women's Health Initiative.
    J Am Coll Cardiol. 2022;79:1594-1603.
    PubMed         Abstract available

  58. DEFILIPPIS EM
    Infertility: A Fertile Ground for Heart Failure?
    J Am Coll Cardiol. 2022;79:1604-1605.
    PubMed        

  59. DRIGGIN E, Cohen LP, Gallagher D, Karmally W, et al
    Nutrition Assessment and Dietary Interventions in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1623-1635.
    PubMed         Abstract available


    J Card Fail

  60. SINGLETON MJ, Nelson MB, Samuel TJ, Kitzman DW, et al
    Left Atrial Stiffness Index Independently Predicts Exercise Intolerance and Quality of Life in Older, Obese Patients With Heart Failure With Preserved Ejection Fraction.
    J Card Fail. 2022;28:567-575.
    PubMed         Abstract available

  61. HONG KN, Battikha C, John S, Lin A, et al
    Cardiac Transplantation in Danon Disease.
    J Card Fail. 2022;28:664-669.
    PubMed         Abstract available

  62. LALA A, Mentz RJ
    #WordsMatter Continued: Moving from "Candidacy" To "Benefit Derived".
    J Card Fail. 2022;28:517-518.
    PubMed        

  63. PARIKH A, Anyanwu AC, Mancini D
    Vasodilatory Shock After Heart Transplantation: the Enigma Continues.
    J Card Fail. 2022;28:627-629.
    PubMed        

  64. ZHU Z, Zhu J, Yu J, Xu K, et al
    Percutaneous Ventricular Restoration Prevents Left Ventricular Remodeling Post Myocardial Infarction: One-Year Evaluation of the Heartech First-in-man Study.
    J Card Fail. 2022;28:604-613.
    PubMed         Abstract available

  65. MAULION C, Januzzi JL
    Risk Prediction Scores in Cardiovascular Disease: Useful Tool or "Model of the Week"?
    J Card Fail. 2022;28:551-553.
    PubMed        

  66. DEFILIPPIS EM, Psotka MA, Khazanie P, Cowger J, et al
    Exploring Physician Perceptions of the 2018 United States Heart Transplant Allocation System.
    J Card Fail. 2022;28:670-674.
    PubMed         Abstract available

  67. BATCHELOR RJ, Wong N, Liu DH, Chua C, et al
    Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes.
    J Card Fail. 2022;28:617-626.
    PubMed         Abstract available


    J Cardiol

  68. KIUCHI S, Ikeda T
    Management of hypertension associated with cardiovascular failure.
    J Cardiol. 2022;79:698-702.
    PubMed         Abstract available

  69. NODA T, Lu X, Ishiguro Y, Ikuemonisan J, et al
    Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling.
    J Cardiol. 2022;79:734-739.
    PubMed         Abstract available

  70. YOKOYAMA Y, Kataoka N, Nakai M, Matsuo A, et al
    A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    J Cardiol. 2022;79:727-733.
    PubMed         Abstract available

  71. AMIOKA N, Takaishi A, Nakamura K, Endo T, et al
    Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
    J Cardiol. 2022 Apr 12. pii: S0914-5087(22)00074.
    PubMed         Abstract available


    PLoS Med

  72. LAMBERT AM, Parretti HM, Pearce E, Price MJ, et al
    Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003960.
    PubMed         Abstract available


    PLoS One

  73. SHROUT TA, Pan S, Mitchell GF, Vasan RS, et al
    Association of orthostatic blood pressure response with incident heart failure: The Framingham Heart Study.
    PLoS One. 2022;17:e0267057.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: